1. Scrip
  2. >>Business

Takeda To Unlock More Cash As It Preps For Shire

 
• By Ian Haydock

Takeda is aiming to free up more cash through asset disposals to help fund its planned acquisition of Shire.

Japanese yen
TAKEDA SEEKS FREE CASH AHEAD OF SHIRE DEAL • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. is looking to raise a higher total of JPY190bn ($1.74bn) in unlocked cash by the end of its current fiscal year to next March 31, to help fund its planned $62bn acquisition of Shire PLC.

The figure is up from the JPY130bn guidance given in May last year, and will be funded by the disposal...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

China Signals Restarting IPOs For Unprofitable Biotechs

 
• By Dexter Jie Yan

The China Securities Regulatory Commission has proposed a new “growth tier” for the STAR Market of the Shanghai Stock Exchange, to reinstate the market’s listing standards for unprofitable firms.

BIO Notebook: Woodcock Calls For Doing The Right Thing, Dealmaking Remains Constrained

 
• By Mandy Jackson, Joseph Haas, and Sarah Karlin-Smith

Highlights from Day Four of the BIO International Convention include Woodcock offering practical advice on rare disease trials, the sorry state of dealmaking mid-year, Novartis discussing its approach to partnering, and Generate looking for funding to move into Phase III.

Syncona Looks To Go Private As Market Decline Deepens

 
• By Andrew McConaghie

While some are calling for Syncona to be wound up, the UK-based company believes many existing and new investors will back the creation of new private fund.